SCHEMBL2028640

SCHEMBL2028640

Cc1ccc(C[C@H](N)C(=O)O)c(O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.62
USP2 O75604 3/20 0.62
ALOX15 P16050 3/20 0.62
HSD17B10 Q99714 3/20 0.62
HIF1A Q16665 3/20 0.62
LMNA P02545 3/20 0.62
MAPT P10636 3/20 0.62
BLM P54132 3/20 0.62
PMP22 Q01453 3/20 0.62
KMT2A Q03164 3/20 0.62
RECQL P46063 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
CYP3A4 P08684 2/20 0.62
PKM P14618 2/20 0.62
NFKB1 P19838 2/20 0.62
ALDH1A1 P00352 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
MEN1 O00255 2/20 0.62
RGS12 O14924 1/20 0.62
CYP2C9 P11712 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2028058 1.00 KDM4E (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2028643 1.00 KDM4E (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2032864 0.87 THRB (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2033125 0.87 THRB (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2033124 0.87 THRB (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL30543993 0.85 USP2 (0.51) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL14640299 0.85 USP2 (0.51) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL668470 0.85 USP2 (0.50) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL668469 0.85 USP2 (0.50) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL29351668 0.85 USP2 (0.50) KDM4EUSP2ALOX15HSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633630-B2 Acceleration of Mycobacterium growth ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) 2020-04-28 US disclosed
EP-3158053-B1 ACCELERATION OF MYCOBACTERIUM GROWTH ST GEORGES HOSPITAL MEDICAL SCHOOL (GB) 2019-03-13 EP disclosed
US-9707282-B2 Small cationic antimicrobial peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-07-18 US disclosed
US-20170121672-A1 ACCELERATION OF MYCOBACTERIUM GROWTH ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) 2017-05-04 US disclosed
EP-3158053-A1 ACCELERATION OF MYCOBACTERIUM GROWTH St. George's Hospital Medical School (GB) 2017-04-26 EP disclosed
WO-2015193688-A1 ACCELERATION OF MYCOBACTERIUM GROWTH ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) 2015-12-23 WO disclosed
US-20150315240-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2015-11-05 US disclosed
US-9017656-B2 Small cationic antimicrobial peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2015-04-28 US disclosed
EP-2061886-B1 Small cationic immunomodulatory peptides UNIV BRITISH COLUMBIA (CA) 2014-05-07 EP disclosed
US-20130266597-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-10-10 US disclosed
US-8343475-B2 Small cationic antimicrobial peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-01-01 US disclosed
US-20110236429-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2011-09-29 US disclosed
US-20110150917-A1 Small Cationic Antimicrobial Peptides THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2011-06-23 US disclosed
EP-2061886-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES The University of British Columbia (CA) 2009-05-27 EP disclosed
WO-2008151434-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2008-12-18 WO disclosed
WO-2008022444-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2008-02-28 WO disclosed
EP-0347766-A2 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as medicaments Dr. Karl Thomae GmbH (DE) 1989-12-27 EP disclosed